Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
02/2007
02/15/2007WO2007017954A1 Maltose-1-phosphate-producing enzyme
02/15/2007WO2007017915A2 Use of common ϝ chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes.
02/15/2007WO2007017201A1 Generation of antigen specific t cells
02/15/2007WO2007017050A2 Method for isolating stem cells and stem cells derived from a pad-like tissue of teeth
02/15/2007WO2007016831A1 The production of many kinds of organisms, enzymes, cells, organs and technique thereof
02/15/2007WO2007016792A1 Orf11 from campylobacter jejuni is a sialate-o-acetyltransferase
02/15/2007WO2007016764A1 Composition and method for prevention and treatment of type i diabetes
02/15/2007WO2006138005A8 Genes and uses for plant improvement
02/15/2007WO2006128163A3 Transgenic alzheimer's mouse model vectors and uses thereof
02/15/2007WO2006113731A9 Bone marrow-derived neurogenic cells and uses thereof
02/15/2007WO2006104609A9 Isolated myeloid-like bone marrow cell populations and methods of treatment therewith
02/15/2007WO2006073446A9 Peptide-mediated protein transduction into cells the hematopoietic lineage
02/15/2007WO2006060769A3 Methods and materials for expression of a recombinant protein
02/15/2007WO2005013904A3 Sars nucleic acids, proteins, vaccines, and uses thereof
02/15/2007US20070039076 for generation of environmentally tailored crops; enhanced water and nitrogen use efficiency, cold tolerance, increased yield, enhanced seed protein and seed oil; nucleic acid molecule encoding a serine/threonine protein kinase
02/15/2007US20070039073 Novel synthetic genes for plant gums
02/15/2007US20070039071 Cell signaling genes and related methods
02/15/2007US20070039070 transforming plant cells with a DNA construct comprising nucleic acid sequences, Eucalyptus caffeic acid 3-O-methyltransferase (COMT) promoters and nucleic acid sequence that code for polypeptides, then culturing said transformed plant cells, to producing transgenic plants
02/15/2007US20070039068 High threonine producing lines of nicotiana tobacum and methods for producing
02/15/2007US20070039067 Nucleotide sequences and polypeptides encoded thereby useful for modifying plant characteristics
02/15/2007US20070039064 Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse
02/15/2007US20070039063 Trangenic diploid cell comprising mutation in kinase allele for use in screening modulator for treatment of anxiety, addiction, withdrawal syndrome, skeletal muscle spasms, convulsive seizures and epilepsy
02/15/2007US20070038384 Devices and assays for monitoring/measuring cellular dynamics to create subject profiles from primary cells
02/15/2007US20070037964 Chemoselective ligation
02/15/2007US20070037745 Nucleic acid and corresponding protein entitled 213P1F11 useful in treatment and detection of cancer
02/15/2007US20070037736 Therapeutic composition comprising the KAL protein and use of the KAL protein for the treatment of retinal, renal, neuronal and neural injury
02/15/2007US20070037284 Vectors for expressing exogenous gene or exogenous nucleic acid sequences
02/15/2007US20070037283 harvesting and purifying a renal capsule to provide an extracellular matrix material having beneficial use as a tissue graft and/or cell growth material
02/15/2007US20070037282 Method of producing lens cell and lens cell obtained by the method
02/15/2007US20070037281 Method for differentiating stem cells in cells that produce a pancreatic hormone
02/15/2007US20070037280 Method for generating primate trophoblasts
02/15/2007US20070037279 Cell culture system
02/15/2007US20070037269 Mutants of desoxycytidine kinase having extended enzymatic activity
02/15/2007US20070037255 Antibody variants with faster antigen association rates
02/15/2007US20070037254 Expression Vectors and Methods
02/15/2007US20070037251 Novel protein expression system
02/15/2007US20070037245 Method of posttranslational modification by adding mycrosomal membrane in cell-free protein synthesis
02/15/2007US20070037222 Lineage restricted glial precursors
02/15/2007US20070037219 Rhesus monkey bombesin receptor subtype-3 (brs-3), nucleotides encoding same, and uses thereof
02/15/2007US20070037218 Human gene critical to fertility
02/15/2007US20070037216 Dual expression vector system for antibody expression in bacterial and mammalian cells
02/15/2007US20070037205 Methods and apparatus for cell based screening
02/15/2007US20070037203 Novel 21910, 56634, 55053, 2504, 15977, 14760, 25501, 17903, 3700, 21529, 26176, 26343, 56638, 18610, 33217, 21967, H1983, M1983, 38555 or 593 molecules and uses therefor
02/15/2007US20070037202 Potentiation of cancer therapies by ZNF217 inhibition
02/15/2007US20070037188 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's diseases; contacting a target cell with a test compound, measuring the levels of reporter gene transcription that occurs in the presence and absence of the test compound; comparing the levels of reporter gene transcription
02/15/2007US20070037178 Endocrine cell lines and method of using the same
02/15/2007US20070037145 drug screening; for carcinomas, especially lymphoma carcinomas
02/15/2007US20070037136 Harvesting, separating, culturing and exposing tissue to antiproliferative agents, monitoring variation in tissue propagation; immunotherapeutics; wound healing agents
02/15/2007US20070037132 Separation of platelets from fluid suspensions
02/15/2007US20070036818 Fabricated in baculovirus; for penetration into human erythrocytes in event of infection; vaccines against malaria
02/15/2007US20070036813 Expression vector comprising nucleotide sequences coding endothelial growth factor protein for use in prevention and treatment of cell proliferative and eye disorders
02/15/2007US20070036796 For treating immunosuppressive diseases; AIDS
02/15/2007US20070036794 Agonist anti-trkC monoclonal antibodies, directed against epitopes in extracellular domain of trkC receptor, which mimic biological activities of NT-3, the natural ligand of trkC receptor, but are free of some of known detriments of NT-3; use of theseagonist antibodies treatment of neuropathy
02/15/2007US20070036788 Use of a compound for reducing the biological effectiveness of il-6
02/15/2007US20070036784 Medicament for the protection against thrombotic diseases
02/15/2007US20070036783 Antibody complexes
02/15/2007US20070036780 Modified proteins, designer toxins, and methods of making thereof
02/15/2007US20070036774 Liver engrafting cells, assays, and uses thereof
02/15/2007US20070036773 Generation and application of universal T cells for B-ALL
02/15/2007US20070036772 Directed in vitro differentiation of marrow stromal cells into neural cell progenitors
02/15/2007US20070036769 BMP pathway methods and compositions
02/15/2007US20070036768 Systems and methods for treating patients with processed lipoaspirate cells
02/15/2007US20070036767 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same
02/15/2007US20070036766 Tissue graft composition comprising autologous bone marrow and purified autologous thrombin
02/15/2007US20070036763 Interleukin-17 receptor homologue
02/15/2007US20070036756 Method for treating ischemic diseases
02/15/2007US20070036734 Therapeutic agent for periodontal disease
02/15/2007DE10336152B4 Aufreinigungsverfahren für humane mesenchymale Stammzellen Purification method for human mesenchymal stem cells
02/15/2007DE102006025680A1 Herstellung multipotenter Stammzellen und deren Verwendung Production of multipotent stem cells and their use
02/15/2007CA2659945A1 Improved methods of reprogramming animal somatic cells
02/15/2007CA2658678A1 Composition and method for prevention and treatment of type i diabetes
02/15/2007CA2619443A1 Glypican-3 (gpc3)-derived tumor rejection antigenic peptides useful for hla-a2-positive patients and pharmaceutical comprising the same
02/15/2007CA2618769A1 Orf11 from campylobacter jejuni is a sialate-o-acetyltransferase
02/15/2007CA2618580A1 Use of common .gamma. chain cytokines for the visualization, isolation and genetic modification of memory t lymphocytes
02/15/2007CA2617483A1 Modified influenza virus for monitoring and improving vaccine efficiency
02/15/2007CA2616437A1 Method for isolating stem cells and stem cells derived from a pad-like tissue of teeth
02/15/2007CA2616069A1 Suppression of b-cell apoptosis in transgenic animals expressing humanized immunoglobulin
02/14/2007EP1752540A2 Non-human mutant mammals deficient in sigma receptors and their applications
02/14/2007EP1752168A2 Augmentation of organ function
02/14/2007EP1752163A1 Agent for actively restoring structure and functions of damaged tissues and organs
02/14/2007EP1752160A2 Epitope sequences
02/14/2007EP1751661A2 Method for selectively expanding, selecting and enriching stem/progenitor cell populations
02/14/2007EP1751291A1 Recombinant lentiviral vector for expression of a flaviviridae protein and applications thereof as a vaccine
02/14/2007EP1751290A2 Alphavirus replicon packaging constructs
02/14/2007EP1751289A1 Tc-83-derived alphavirus vectors, particles and methods
02/14/2007EP1751282A2 Production of host cells containing mutiple integrating vectors by serial transduction
02/14/2007EP1751280A2 Tobacco nicotine demethylase genomic clone and uses thereof
02/14/2007EP1751274A1 Method for producing pluripotent cells from monocytesmethod for producing pluripotent cells from monocytes
02/14/2007EP1751267A1 Patterned cell network substrate interface and methods and uses thereof
02/14/2007EP1751191A2 Antibodies to angiogenesis inhibiting domains of cd148
02/14/2007EP1751187A2 Canine cd20 compositions
02/14/2007EP1750791A2 Devices and methods for protecting against distal embolisms
02/14/2007EP1750773A1 Drugs for the prevention or treatment of immunodeficiencies, autoimmune diseases or for the induction of immune tolerance
02/14/2007EP1750764A2 Antibodies of angiogenesis inhibiting domains of cd148
02/14/2007EP1750497A2 A method for producing direct in vitro flowering and viable seed from cotyledon, radicle, and leaf explants and plants produced therefrom
02/14/2007EP1689878A4 Method for maintaining low shear in a bioprocessing system
02/14/2007EP1565737A4 Isolation of sperm cells from other biological materials using microfabricated devices and related methods thereof
02/14/2007EP1546388A4 Real time measurement of cellular responses
02/14/2007EP1328645B1 Mutant trichoderma reesei egiii cellulases, dna encoding such egiii compositions and methods for obtaining same
02/14/2007EP1326673B1 Microstructures for treating and conditioning skin